Table 4.

Examples of types and sources of evaluation data used by committees

Process (implementation) and Impact (practice change)

▪ Progress Reports for new TCPs including number of patients treated, number waiting, new referrals (6 monthly)

▪ Medication safety audits (twice yearly)

▪ Continual Review Evaluation through Australian Council of Healthcare Standards Guide (dates in Nursing Strategic Plan)

▪ Established surveillance mechanisms of transfusion practices (ongoing)

▪ Audits of transfusion practice (random, on behalf of Department of Human Services)

▪ Incident reports (as they arise, documented in Riskman software)

Practitioner outcomes

▪ Survey/interview data including user satisfaction and comments (after project implementation)

▪ Clinical practice audits (quarterly)

▪ Incident reports (as they arise, documented in Riskman software)

Patient outcomes

▪ Progress Reports for new TCPs including patient outcomes and adverse events (6 monthly)

▪ Reports of adverse events related to new TCPs (at the time of occurrence)

▪ Infection Control surveillance mechanisms (ongoing)

▪ Incident reports (as they arise, documented in Riskman software)

Economic outcomes

▪ Clinical Information Management databases of routinely-collected data used to assess

− Cost of falls and falls-related injuries (as required)

− Cost of increased length of stay (as required)

− Costs of products (as required)

− Costs of procedures (as required)

System outcomes

▪ Applications for new TCPs including anticipated implications of new TCP on other areas such as intensive care or pharmacy

▪ Reports of 2 year review after introduction of new TCP including actual implications of new TCP on other areas